Clinical Trial Update: Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

View source ↗

Summary

This clinical trial update describes the completion of an observational study comparing the rate and extent of intraocular inflammation after a single intravitr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)
• Lucentis (ranibizumab)

Snippet

Sponsor: Prism Vision Group | Conditions: Neovascular Age Related Macular Degeneration | Status: COMPLETED